Results 181 to 190 of about 54,372 (262)

Ethical guidelines for geoprivacy: a framework for researchers and ethics committees. [PDF]

Int J Health Geogr
Malekzadeh M, Kestens Y, Blanford JI, Perchoux C, Mostafavi MA, McKenzie G, Kim EK.   +6 more
europepmc   +1 more source

Anonymized event log and corresponding analysis using LLMs

Juan Antonio Caballero-Hernández
openalex   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Arthritis &Rheumatology, EarlyView.
Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana   +10 more
wiley   +1 more source

Real-Time Stream Data Anonymization via Dynamic Reconfiguration with <i>l</i>-Diversity-Enhanced SUHDSA. [PDF]

Sensors (Basel)
Lee J, Kim S.
europepmc   +1 more source

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

Arthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Correction: Evaluation of the initial timing of infection control pharmacist-driven audit and monitoring of vancomycin therapy in patients with infectious diseases: A retrospective observational study. [PDF]

PLoS One
Sugita H, Okada N, Okamoto M, Abe K, Sekido M, Tanaka M, Tamatukuri T, Naito Y, Yoshikawa M, Inoue E, Tanaka H.   +10 more
europepmc   +1 more source

Strategies for De-identification and Anonymization of Electronic Health Record Data for Use in Multicenter Research Studies

, 2012
Clete A. Kushida, Deborah A. Nichols, Rik Jadrnicek, Ric Miller, James K. Walsh, Kara Griffin   +5 more
openalex   +2 more sources

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source

Federated learning for teacher data privacy protection: a study in the context of the PIPL. [PDF]

Front Big Data
Chen S, Qi XZ, Han XH, Fan ZC, Wang LL.
europepmc   +1 more source

PTA: An Efficient System for Transaction Database Anonymization

, 2016
Jerry Chun‐Wei Lin, Qiankun Liu, Philippe Fournier‐Viger, Tzung‐Pei Hong   +3 more
openalex   +1 more source